News

As per the terms of the licensing and supply agreement, Par Pharmaceutical has made a payment to Glenmark for exclusive rights to commercialise Ezetimibe in the US. The

Vimovo, co-developed by Pozen and AstraZeneca, is a fixed-dose combination of delayed-release enteric-coated naproxen, a pain-relieving NSAID, and immediate-release esomeprazole, a proton pump inhibitor (PPI). Reportedly, the FDA

Watson’s ANDA is for a generic equivalent of Abbott’s Trilipix product. The suits were filed on April 27, 2010 and April 29, 2010 in the US District Court

arvato services healthcare said that this new approach is based on its expertise and network and is expected to enable US and other non-European companies to furnish medical

Norwich Clinical Services is expected to offer a complete range of clinical research capabilities including Phase I – IV trials, bioanalytical studies and pharmacovigilance monitoring services. Norwich Clinical

The study was presented by William White, professor of school of medicine at University of Connecticut. Naproxcinod is the CINOD (Cyclooxygenase-Inhibiting Nitric Oxide-Donating) anti-inflammatory drug-candidate developed for the

McNeil Consumer Healthcare is initiating this voluntary recall because some of these products may not meet required quality standards. This recall is not being undertaken on the basis

As per the terms of the agreement, Perrigo acquired 100% of the shares of PBM Holdings for $808m in cash. Pursuant to the agreement, Perrigo and PBM expect

Prior to joining GVK Bio, Dr Ellingboe worked with Wyeth Research and Pfizer for 25 years in senior scientific positions and has extensive background in medicinal chemistry and